Search & Analyze

Poly Medicure Ltd.

1,447.80−15.10 (−1.03%)

BSE · 30 Oct, 4:01 PM

: ₹14,676.13 Cr
: 46.58
: 4,039
: ₹1,476.00 - ₹1,432.05
: ₹2,093.95 - ₹1,184.00

Poly Medicure Ltd. (POLYMED) share price closed at ₹1,447.80 on the BSE on Friday, October 30, 2026, down by 1.03% from its of ₹1,462.90. In that session POLYMED reached a of 1,476.00 and of 1,432.05. The for the session was 1,453.32. The stands at 1,651.42 and is at 1,548.81. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹1,468.85

₹1,462.90

₹1,453.32

₹1,651.42

Price 12.33% below

₹1,548.81

Price 6.52% below

Key Fundamentals

: 14,676.13 Cr₹14.68 Thousand Crore
: 31.09
: 46.58
: 4.61
: 313.97
: 572.73 Cr₹572.73 Crore
: 0.24 %
Sector
Industry: Medical Equipment/Supplies/Accessories
: 10.94
: 0.11

Industry Comparison

Ratio	Company	Sector
	46.58	44.77
	0.11	0.20
	4.61	4.61
	3.05	1.81
	0.24 %	0.11 %
Operating Margin	23.24 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
LENSKART LENSKART	678.20	179.99	1,17,959.74	0.00	228.43	273.43%	2,714.18	43.27%	12.55
MOLBIO MOLBIO	1,274.65	88.17	14,689.07	0.00	52.74	320.28%	408.38	309.57%	19.79
Poly Medicure Ltd. POLYMED	1,447.80	46.58	14,676.13	0.24	85.27	-8.39%	525.38	30.30%	14.05
SMT SMT	459.95	71.61	4,675.24	0.00					11.93
3BBLACKBIO 3BBLACKBIO	1,298.95	20.04	1,114.85	0.39	8.98	-28.99%	33.49	50.62%	25.90
LAXMIDENTL LAXMIDENTL	177.80	31.67	978.42	0.00	10.32	23.83%	74.70	13.87%	13.29
GKB OPHTHA GKB	59.00	9.06	29.74	0.00	1.85	387.99%	33.04	2.28%	8.82

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	378.07	384.78	420.02	424.21	440.83	403.21	443.88	493.66	534.51	525.38
Expenses	281.61	280.98	304.83	309.81	321.23	296.96	329.20	382.47	424.11	400.28
	96.46	103.79	115.19	114.40	119.60	106.25	114.68	111.18	110.40	125.10
	25.51%	26.97%	27.42%	26.97%	27.13%	26.35%	25.84%	22.52%	20.65%	23.81%
	14.97	16.92	26.10	21.80	24.31	41.69	33.94	19.46	17.76	33.41
Interest	3.13	3.16	3.34	3.33	2.17	2.95	2.97	5.96	6.41	6.50
	16.08	19.53	20.71	21.37	21.17	23.37	24.93	28.76	38.23	36.25
	92.46	98.46	117.98	113.23	122.85	122.95	121.69	97.61	85.22	117.30
	26.07%	24.80%	25.87%	24.73%	25.25%	24.29%	24.56%	27.46%	23.68%	27.31%
	68.36	74.04	87.46	85.23	91.83	93.08	91.84	70.93	66.29	86.03
	7.12	7.71	8.63	8.41	9.06	9.19	9.06	7.00	6.54	8.49

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	927.34	1,119.77	1,381.06	1,677.15	1,886.84
	923.06	1,115.23	1,375.80	1,669.83	1,875.26
EXPENDITURE :
Increase/Decrease in Stock	-14.95	-23.65	10.80	-23.86	-7.64
Raw Material Consumed	296.55	345.37	382.51	471.68	496.81
Power & Fuel Cost	29.84	38.59	44.29	53.56	59.94
Employee Cost	163.62	202.75	245.91	301.53	402.26
Other Manufacturing Expenses	172.94	208.57	234.53	287.46	302.61
General and Administration Expenses	32.52	38.99	49.42	58.19	86.45
Selling and Distribution Expenses	15.68	20.99	27.25	43.35	63.03
Miscellaneous Expenses	11.86	16.23	21.08	22.20	33.20
	708.05	847.83	1,015.80	1,214.12	1,436.66
Operating Profit (Excl OI)	215.01	267.40	360.00	455.71	438.59
	37.90	36.19	58.75	89.13	126.93
	252.91	303.59	418.75	544.84	565.53
Interest	6.16	10.86	13.56	14.32	21.42
PBDT	246.75	292.73	405.19	530.52	544.11
	53.95	57.17	63.44	83.18	115.52
Profit Before Taxation & Exceptional Items	192.80	235.56	341.74	447.34	428.59
Exceptional Income / Expenses					-6.80
	195.24	237.49	344.27	452.52	427.47
Provision for Tax	48.74	58.21	86.01	113.96	106.74
	146.51	179.28	258.26	338.56	320.73
Extra items				0.00	0.00
Minority Interest					1.41
Consolidated Net Profit	146.51	179.28	258.26	338.56	322.14
Profit Balance B/F	304.17	399.04	527.75	730.85	1,013.64
Appropriations	450.67	578.32	786.01	1,069.41	1,335.78
Equity Dividend %	50.00%	60.00%	60.00%	70.00%	70.00%
	15.28	18.69	26.91	33.41	31.78
Adjusted EPS	15.28	18.69	26.91	33.41	31.78

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	47.95	47.97	47.99	50.66	50.68
Share Warrants & Outstandings	1.53	2.31	3.40	2.28	7.44
Total Reserves	1,038.01	1,191.35	1,418.67	2,712.71	3,048.05
Reserve excluding Revaluation Reserve	1,038.01	1,191.35	1,418.67	2,712.71	3,048.05
Revaluation reserve			0.00
	1,087.48	1,241.63	1,470.05	2,765.66	3,106.17
Minority Interest					43.07
Secured Loans	30.56	11.56	0.84		5.67
Unsecured Loans	7.56	5.94			46.42
Deferred Tax Assets / Liabilities	16.13	15.43	24.46	42.54	-15.67
Other Long Term Liabilities	4.43	4.74	5.82	4.43	52.68
Long Term Provisions	3.98	4.60	6.26	9.43	31.07
Total Non-Current Liabilities	62.68	42.28	37.38	56.40	120.16
Trade Payables	89.04	92.31	95.60	86.32	122.67
Other Current Liabilities	78.57	92.72	100.85	101.80	179.55
Short Term Borrowings	58.72	106.88	150.91	174.70	262.15
Short Term Provisions	0.35	59.25	77.23	94.88	102.17
Total Current Liabilities	226.68	351.17	424.59	457.71	666.53
Total Liabilities	1,376.83	1,635.07	1,932.02	3,279.77	3,935.93
Gross Block	818.46	1,018.82	1,311.18	1,596.05	2,476.07
Less: Accumulated Depreciation	334.23	384.47	444.38	511.73	782.08
	484.23	634.35	866.81	1,084.32	1,693.99
	37.14	72.58	66.70	89.65	90.51
Non Current Investments	9.77	7.64	27.57	20.51	15.78
Long Term Investment	9.77	7.64	27.57	20.51	15.78
Long Term Loans & Advances	32.25	41.89	38.63	55.50	81.27
Other Non Current Assets	19.88	7.58	7.75	8.49	13.43
Total Non-Current Assets	593.40	770.52	1,017.05	1,269.89	1,903.19
Currents Investments	336.60	124.02	139.54	1,055.79	739.16
Inventories	168.36	208.65	221.03	285.57	433.84
Sundry Debtors	206.63	235.43	269.94	349.73	531.17
Cash and Bank	15.44	177.63	146.86	151.34	87.87
Other Current Assets	12.44	15.75	16.90	16.94	53.01
Short Term Loans and Advances	43.98	103.06	120.71	150.50	187.69
Total Current Assets	783.44	864.55	914.98	2,009.87	2,032.74
Net Current Assets (Including Current Investments)	556.76	513.39	490.39	1,552.17	1,366.21
Total Assets	1,376.83	1,635.07	1,932.02	3,279.77	3,935.93
	69.24	69.07	113.16	77.12	50.21
Total Debt	125.27	146.43	169.97	177.65	341.62
	113.24	129.17	152.82	272.72	305.72
Adjusted Book Value	113.24	129.17	152.82	272.72	305.72

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	195.24	237.49	344.27	452.52	427.47
Adjustment	39.08	60.89	36.77	28.29	69.57
Changes In working Capital	-63.39	-49.46	-40.66	-155.34	-148.92
Cash Flow after changes in Working Capital	170.93	248.92	340.38	325.46	348.12
Cash Flow from Operating Activities	123.47	191.05	266.08	233.05	246.37
Cash Flow from Investing Activities	-85.33	-179.24	-240.94	-1,187.18	-225.38
Cash Flow from Financing Activitie	-35.34	-12.51	-20.15	950.51	20.15
Net Cash Inflow / Outflow	2.80	-0.70	4.99	-3.63	41.14
Opening Cash & Cash Equivalents	4.95	7.76	7.06	12.05	8.70
Effect of Foreign Exchange Fluctuations				0.27	1.38
Closing Cash & Cash Equivalent	7.76	7.06	12.05	8.70	51.23

Ratios

Valuation

46.58

4.61

26.07

7.35

31.09

313.97

Profitability

10.94

14.05

8.89

23.24

17.00

Leverage & Liquidity

0.11

3.05

20.96

Returns

0.24

0.52

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	66.03	62.56	62.44	62.44	62.44	62.42	62.42	62.42	62.42	62.42
	19.26	24.20	23.99	23.42	23.13	23.31	23.24	21.50	21.65	21.25
	14.72	13.24	13.57	14.15	14.44	14.27	14.34	16.08	15.94	16.33
	33.97	37.44	37.56	37.56	37.56	37.58	37.58	37.58	37.58	37.58
No. of Shareholders	36,852	38,352	60,686	65,583	71,142	64,400	67,750	73,414	73,643	74,153

Mutual Funds Invested(75)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 24 active funds hold 9.47% in Poly Medicure Ltd., contributing to ₹1.61K Cr of holdings

Fund				As of
QU Quant Small Cap Fund - Growth - Direct PlanSmall cap Fund	729.28	2.05	43,57,016	Sep '26
UT UTI Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	228.21	1.01	13,63,413	Sep '26
HS HSBC Midcap Fund - Growth - Direct PlanMid Cap Fund	206.52	1.23	12,33,816	Sep '26
SB SBI Healthcare Opportunities Fund - Growth - Direct PlanPharma & Health Care	107.12	1.82	6,40,000	Sep '26
SB SBI MNC Fund - Growth - Direct PlanMNC	93.73	1.47	5,60,000	Sep '26
WC WhiteOak Capital Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	46.25	0.50	2,76,291	Sep '26
QU Quant Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	44.32	0.59	2,64,798	Sep '26
IN Invesco India Largecap Fund - Growth - Direct PlanLarge Cap Fund	29.06	1.51	1,73,600	Sep '26
WC WhiteOak Capital Mid Cap Fund - Growth - Direct PlanMid Cap Fund	26.01	0.35	1,55,414	Sep '26
WC WhiteOak Capital Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	24.45	0.57	1,46,104	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-29	Board Meeting	Quarterly Results
2026-08-14	AGM
2026-07-31	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareMedical Equipment/Supplies/Accessories

Poly Medicure Ltd. operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

14 members across the board and senior leadership

Devendra Mehta

Chairman

₹28.00 L

Mar '26

Jugal Kishore Baid

Non Independent & Non Executive Director

₹24.50 L

Mar '26

Vimal Bhandari

Non Executive Independent Director

₹25.00 L

Mar '26

Amit Khosla

Non Executive Independent Director

₹28.00 L

Mar '26

Ambrish Mithal

Non Executive Independent Director

₹24.00 L

Mar '26

Sonal Mattoo

Non Executive Independent Director

₹26.00 L

Mar '26

Himanshu Baid

Managing Director

₹18.10 Cr

Mar '26

Alessandro Balboni

Non Independent & Non Executive Director

₹24.00 L

Mar '26

Rishi Baid

Joint Managing Director

₹17.57 Cr

Mar '26

Vishal Gupta

Non Executive Independent Director

₹22.50 L

Mar '26

Vishal Baid

Executive Director

₹9.51 Cr

Mar '26

Pankaj Kumar Gupta

Executive Director

₹1.05 Cr

Mar '26

Avinash Chandra

Company Secretary & Compliance Officer

—

Ravi Prakash

Deputy Company Secretary

—

POLYMED Latest News

News

4 of 4 articles

EQUITY22 Jun 2026 · 16:59

Poly Medicure submits intimation for schedule of investor meet

EQUITY29 May 2026 · 17:15

Poly Medicure submits transcript of conference call

EQUITY25 May 2026 · 15:21

Poly Medicure reports Profit after tax of Rs 806.22 Mln, in the March 2026 quarter

EQUITY20 May 2026 · 16:58

Poly Medicure informs about conference call

Poly Medicure Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(75)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

POLYMED Latest News

News